Organic compounds -- part of the class 532-570 series inventions 02/07

20070043214 - Derivatives of azithromycin: The invention relates to derivatives of azithromycin, processes for the manufacture thereof and pharmaceutical compositions thereof preferably together with azithromycin.... Agent: Novartis Corporate Intellectual Property

20070043215 - Recombinant f1-v plague vaccine: A recombinant vaccine is described which is composed of one recombinant protein comprising F1 and V antigen of Yersinia pestis. This vaccine protects experimental mice against pneumonic as well as bubonic plague produced by either F1+ or F1− strains of Y. pestis and may provide the basis for an improved... Agent: Mcmr Sgrd-ja US Army Mrmc

20070043216 - Compositions and methods for using a solid support to purify rna: Reagents, methods and kits for the purification of RNA from biological materials are provided.... Agent: Viksnins Harris & Padys Pllp

20070037968 - Interleukin-17 receptor homologue: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.”... Agent: Zymogenetics, Inc. Intellectual Property Department

20070037969 - Interleukin-17 receptor homologue: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.”... Agent: Zymogenetics, Inc. Intellectual Property Department

20070037970 - Interleukin-17 receptor homologue: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.”... Agent: Zymogenetics, Inc. Intellectual Property Department

20070032642 - Novel genes and their use in the modulation of obesity, diabetes and energy imbalance: The present invention relates generally to nucleic acid molecules encoding proteins associated with the modulation of obesity, diabetes and/or metabolic energy levels. More particularly, the present invention is directed to nucleic acid molecules and the recombinant and purified proteins encoded thereby and their use in therapeutic and diagnostic protocols for... Agent: Scully Scott Murphy & Presser, PC

20070032643 - Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same: The present invention provides a novel fructose responsive transcription control cis-element and a transcriptional regulatory factor that interacts therewith, a non-human animal having them transferred or inactivated, a diagnostic method for genetic susceptibility to a metabolic disorder using them, and a screening method for a prophylactic or therapeutic drug for... Agent: Edwards & Angell, LLP

20070032644 - Recombinant canine thyroid stimulating hormone and methods of production and use thereof: The invention includes a nucleic acid having a sequence at least 98% homologous to SEQ.ID.NO: 1, which encodes the a subunit of canine TSH. The invention also includes a nucleic acid having a sequence at least 98% homologous to SEQ.ID.NO: 2, which encodes the β subunit of canine TSH. The... Agent: Baker Botts L.L.P.

20070032645 - Method for the preparation of 2-halo-2'-deoxyadenosine compounds for 2'-deoxyguanosine: The present invention is a method for preparing 2-halo-6-aminopurines, and more specifically for preparing the clinical agent cladribine (2-chloro-2′-deoxyadenosine, CldAdo, 4), a drug of choice against hairy-cell leukemia and other neoplasms, from 2-amino-6-oxopurines, which are readily obtained from the naturally occurring compound 2′-deoxyguanosine. According to the methods of the present... Agent: Holland & Hart, LLP

20070027308 - Expressed sequence tags and encoded human proteins: The sequences of 5′ ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5′ ESTs may be to obtain cDNAs and genomic DNAs corresponding to the 5′ ESTs. The 5′ ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also... Agent: Saliwanchik Lloyd & Saliwanchik A Professional Association

20070027309 - Nucleic acid and amino acid sequences relating to candida albicans for diagnostics and therapeutics: The invention provides isolated polypeptide and nucleic acid sequences derived from Candida albicans that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting... Agent: Robert L. Spadafora Genome Therapeutics Corporation

20070027310 - Novel ligands and methods for preparing same: A process is disclosed for modifying a parent ligand by attaching to the parent ligand a conjugation agent that is reactive with a moiety of a target receptor to which the parent ligand binds such that a covalent bond is formable between the conjugation agent and the receptor moiety. Also... Agent: Morrison & Foerster LLP